全文获取类型
收费全文 | 540481篇 |
免费 | 38605篇 |
国内免费 | 14087篇 |
专业分类
耳鼻咽喉 | 5221篇 |
儿科学 | 16769篇 |
妇产科学 | 7976篇 |
基础医学 | 46062篇 |
口腔科学 | 11332篇 |
临床医学 | 58490篇 |
内科学 | 93908篇 |
皮肤病学 | 7042篇 |
神经病学 | 45779篇 |
特种医学 | 13837篇 |
外国民族医学 | 35篇 |
外科学 | 51674篇 |
综合类 | 77766篇 |
现状与发展 | 42篇 |
一般理论 | 38篇 |
预防医学 | 50217篇 |
眼科学 | 7437篇 |
药学 | 44176篇 |
540篇 | |
中国医学 | 37979篇 |
肿瘤学 | 16853篇 |
出版年
2023年 | 9149篇 |
2022年 | 14789篇 |
2021年 | 23647篇 |
2020年 | 22030篇 |
2019年 | 25349篇 |
2018年 | 23265篇 |
2017年 | 20304篇 |
2016年 | 18100篇 |
2015年 | 17327篇 |
2014年 | 33939篇 |
2013年 | 37298篇 |
2012年 | 29913篇 |
2011年 | 32381篇 |
2010年 | 25826篇 |
2009年 | 24232篇 |
2008年 | 23892篇 |
2007年 | 24037篇 |
2006年 | 21243篇 |
2005年 | 18018篇 |
2004年 | 14923篇 |
2003年 | 12989篇 |
2002年 | 10523篇 |
2001年 | 9318篇 |
2000年 | 7731篇 |
1999年 | 6674篇 |
1998年 | 5836篇 |
1997年 | 5356篇 |
1996年 | 4736篇 |
1995年 | 4427篇 |
1994年 | 4184篇 |
1993年 | 3439篇 |
1992年 | 3404篇 |
1991年 | 2951篇 |
1990年 | 2512篇 |
1989年 | 2202篇 |
1988年 | 2069篇 |
1987年 | 1827篇 |
1986年 | 1661篇 |
1985年 | 4484篇 |
1984年 | 5371篇 |
1983年 | 3693篇 |
1982年 | 4221篇 |
1981年 | 3888篇 |
1980年 | 3420篇 |
1979年 | 3140篇 |
1978年 | 2708篇 |
1977年 | 2058篇 |
1976年 | 2272篇 |
1975年 | 1679篇 |
1974年 | 1473篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
血管内超声显像在冠心病支架植入术中的应用 总被引:5,自引:1,他引:4
目的探讨血管内超声在冠心病支架植入中的作用。方法50例患者的52处病变在支架植入前后分别用血管内超声进行定量和定性分析,并根据血管内超声标准决定支架的直径以及植入的终点,分析CAG和IVUS对支架植入终点判断的差异和最终获得的管腔面积大小的差别以及支架后管腔面积增大的机制。结果IVUS比CAG判断的平均支架直径大[(3.48±0.29)mmvs(3.36±0.33)mm,P=0.011],支架囊的最终峰值压力明显增大[(17.7±2.9)atmvs(12.8±2.4)atm,P<0.001],QCA测得的支架面积狭窄百分比减小(13.2%±6.6%vs16.6%±9.1%,P=0.044);首次高压扩张后支架满意率CAG达96.2%,而IVUS只有37.7%。IVUS指导后最终的球囊压力更高[(16.13±1.87)atmvs(12.62±2.61)atm,P<0.001],获得的管腔直径更大[(3.64±0.53)mmvs(3.31±0.57)mm,P<0.001],管腔面积也更大[(9.90±2.05)mm2vs(8.84±1.67)mm2,P<0.001],面积狭窄百分比更小(49.15%±9.03%vs54.24%±10.05%,P<0.001];所有患者支架的近段和远段CAG均未发现明显的狭窄。而IVUS却发现支架近段血管有39例(75.0%),远段血管有23(44.2%)例存在动脉粥样硬化斑块;支架植入后非脂质斑块较脂质斑块获得的管腔面积更大[(4.50±1.67)mm2vs(3.68±0.97)mm2,P<0.001],其中脂质斑块血管面积增大较非脂质斑块小1.30mm2,斑块压缩程度却增加0.48mm2。结论IVUS较CAG能更好地判断病变的性质,指导支架更好地选择,可获得更大的管腔面积,更小的面积狭窄百分比。 相似文献
992.
邻近节指背筋膜(蒂)皮瓣修复手指皮肤软组织缺损 总被引:3,自引:3,他引:0
目的报道应用手指缺损创面的邻近节指背筋膜(蒂)皮瓣修复手指皮肤组织缺损的方法。方法2004年10月~2006年8月,根据受区皮肤缺损的面积及形状,在供区设计斜形皮瓣修复手指皮肤软组织缺损创面共27例。结果皮瓣全部成活,术后3~20个月随访,皮瓣质地优良,外形与感觉功能恢复满意。结论手指缺损创面的邻近节指背筋膜(蒂)皮瓣手术操作简单、安全可靠,术后治疗、护理容易,外形与功能恢复良好,是手外科修复手指皮肤软组织缺损创面较为理想的方法,值得推广。 相似文献
993.
994.
Moussa Ndong Machiko Kazami Tsukasa Suzuki Mariko Uehara Shin-ichi Katsumata Hirohumi Inoue Ken-Ichi Kobayashi Tadahiro Tadokoro Kazuharu Suzuki Yuji Yamamoto 《Nutrition Research》2009,29(9):640-647
Iron deficiency (ID) is one of the most commonly known forms of nutritional deficiencies. Low body iron is thought to induce neurologic defects but may also play a protective role against cancer development by cell growth arrest. Thus, ID may affect cellular pathways controlling cell growth and proliferation, the mechanism of which is still not fully understood. The serine/threonine protein kinase Akt and its downstream target, the mammalian Target of Rapamycin (mTOR), is known to play a crucial role in the regulation of cell growth and survival. Therefore, we hypothesized that Akt/mTOR pathway could be influenced by ID. Three-week-old male Wistar-strain rats were divided into 3 groups and the 2 groups had free access to a control diet (C group) or an iron-deficient diet (D group). The third group (PF group) were pair-fed the control diet to the mean intake of the D group. After 4 weeks, rats were killed and their brains were sampled. In separate experiments, COS-1 cells were cultured with or without the iron chelator deferoxamine. Western blots of brain samples and COS-1 lysates were used to analyze the expression and phosphorylation state of Akt, TSC2, mTOR, and S6 kinase proteins implicated in the Akt/mTOR pathway. Using 2 different ID models, we show for the first time that iron deficiency depresses Akt activity in rats and in COS-1 cells, leading to a decrease in mTOR activity. 相似文献
995.
996.
Robert M. Levy Roman Saikovsky Evgeniya Shmidt Alexander Khokhlov Bruce P. Burnett 《Nutrition Research》2009
Flavocoxid (Limbrel), a proprietary mixture of flavonoid molecules (baicalin and catechin), was tested against a traditional nonsteroidal anti-inflammatory drug, naproxen, for the management of the signs and symptoms of moderate osteoarthritis (OA) in humans. Discomfort and global disease activity were used as the primary end points, and safety assessments were also taken for both treatments as a secondary endpoint. In this double-blind study, 103 subjects were randomly assigned to receive either flavocoxid [500 mg twice daily (BID)] or naproxen (500 mg BID) in a 1-month onset of action trial. Outcome measures included the short Western Ontario and McMaster University Osteoarthritis Index, subject Visual Analogue Scale for discomfort and global response, and investigator Visual Analogue Scale for global response and fecal occult blood. Both flavocoxid and naproxen showed significant reduction in the signs and symptoms of knee OA (P ≤ .001). There were no statistically detectable differences between the flavocoxid and naproxen groups with respect to any of the outcome variables. Similarly, there were no statistically detectable differences between the groups with respect to any adverse event, although there was a trend toward a higher incidence of edema and nonspecific musculoskeletal discomfort in the naproxen group. In this short-term pilot study, flavocoxid was as effective as naproxen in controlling the signs and symptoms of OA of the knee and would present a safe and effective option for those individuals on traditional nonsteroidal anti-inflammatory drugs or cyclooxygenase-2 inhibitors. A low incidence of adverse events was reported for both groups. 相似文献
997.
背景:Nissen胃底折叠术(Nissen fundoplication,NF)已不是治疗胃食管返流性疾病(gastroesophageal reflux disease,GERD)的唯一、有效的方法。对于能降低胃酸的手术方式来讲,如高选择性迷走神经切断术(highly selective vagotomy,HSV),也不仅仅是一种辅助治疗方法。对高选择性迷走神经切断术联合Nissen胃底折叠术(Nissen fundoplication with highly selective vagotomy,NFHSV)治疗GERD的作用目前尚无完整的评价。方法:2003年6月~2005年6月8例女性病人接受NFHSV,8例均有6个月GERD病史,经药物治疗症状无缓解,有餐前痛、消化性溃疡或严重的胃炎。平均随访时间12个月,术前、术后进行烧心严重程度评分测定(heart burn severity score,HSS)。结果:平均手术时间110min,无手术并发症。1例术后须用质子泵抑制剂,术后经戒烟5个月后停药。8例术后症状和烧心严重程度评分测定有明显改善。结论:NFHSV是有效的联合手术方式,尚需要进一步的研究证实这一联合术式的完全有效性和安全性。 相似文献
998.
Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients 总被引:1,自引:0,他引:1
A. Åsberg A. Humar H. Rollag A. G. Jardine H. Mouas M. D. Pescovitz D. Sgarabotto M. Tuncer I. L. Noronha A. Hartmann 《American journal of transplantation》2007,7(9):2106-2113
Intravenous ganciclovir is the standard treatment for cytomegalovirus disease in solid organ transplant recipients. Oral valganciclovir is a more convenient alternative. In a randomized, international trial, recipients with cytomegalovirus disease were treated with either 900 mg oral valganciclovir or 5 mg/kg i.v. ganciclovir twice daily for 21 days, followed by 900 mg daily valganciclovir for 28 days. A total of 321 patients were evaluated (valganciclovir [n = 164]; i.v. ganciclovir [n = 157]). The success rate of viremia eradication at Day 21 was 45.1% for valganciclovir and 48.4% for ganciclovir (95% CI -14.0% to +8.0%), and at Day 49; 67.1% and 70.1%, respectively (p = NS). Treatment success, as assessed by investigators, was 77.4% versus 80.3% at Day 21 and 85.4% versus 84.1% at Day 49 (p = NS). Baseline viral loads were not different between groups and decreased exponentially with similar half-lives and median time to eradication (21 vs. 19 days, p = 0.076). Side-effects and discontinuations of assigned treatment (18 of 321 patients) were comparable. Oral valganciclovir shows comparable safety and is not inferior to i.v. ganciclovir for treatment of cytomegalovirus disease in organ transplant recipients and provides a simpler treatment strategy, but care should be taken in extrapolating to organ transplant recipients not properly represented in the present study. 相似文献
999.
Dwight Dickinson Virginia N Iannone Christopher M Wilk James M Gold 《Neuropsychopharmacology》2004,55(8):826-833
BACKGROUND: It is controversial whether the cognitive deficit in schizophrenia is better characterized as generalized or as reflecting relatively independent deficits in different cognitive domains. The issue has implications for assessment practice, intervention design, and the exploration of schizophrenia genetics. METHODS: We used a specialized structural equation modeling approach, single common factor analysis, to explore the relative importance of generalized versus independent cognitive deficits in schizophrenia. Eighteen subtest scores from the Wechsler Adult Intelligence Scale-III and the Wechsler Memory Scale-III were included in the analysis. We analyzed these data for 97 schizophrenia or schizoaffective disorder outpatients and 87 healthy control subjects. RESULTS: Approximately two thirds of the overall effect of a schizophrenia diagnosis on cognitive performance was mediated through a single common factor. The Wechsler subtest scores showed almost uniformly strong relationships with this factor. The independent associations of group status with the subtest scores were smaller in magnitude and only selectively significant. CONCLUSIONS: The relatively greater magnitude of illness effects mediated through the common factor in this analysis, compared with the specific, independent effects, suggests that a generalized cognitive deficit is a core feature of schizophrenia. 相似文献
1000.
冠状动脉搭桥术193例经验总结 总被引:2,自引:0,他引:2
目的:探讨冠状动脉搭桥术的病例选择、手术方法和治疗效果。方法:回顾性分析1997年1月~至2003年12月齐鲁医院施行的体外循环下冠状动脉搭桥术穴CPBCABG雪99例,非体外循环冠状动脉搭桥术穴OPCABG雪74例,冠状动脉搭桥加瓣膜置换术穴CABG VP雪20例的临床资料。结果:手术死亡6例,死亡率3.1%。体外循环下单纯冠状动脉搭桥术死亡率为2%,非体外循环冠状动脉搭桥术死亡率为2.7%,冠状动脉搭桥加瓣膜置换术死亡率为10%。短期随访3~6个月,症状消失占93.0%,症状明显减轻占5.4%。结论:患者近期随访效果良好,3组的手术死亡率差异无统计学意义穴P>0.05雪。 相似文献